LT3005B - Tam tikru terapiskai aktyviu 4-pakeistu imidazolu panaudojimas perodiniu farmaciniu preparatu gamybai - Google Patents

Tam tikru terapiskai aktyviu 4-pakeistu imidazolu panaudojimas perodiniu farmaciniu preparatu gamybai Download PDF

Info

Publication number
LT3005B
LT3005B LTIP111A LTIP111A LT3005B LT 3005 B LT3005 B LT 3005B LT IP111 A LTIP111 A LT IP111A LT IP111 A LTIP111 A LT IP111A LT 3005 B LT3005 B LT 3005B
Authority
LT
Lithuania
Prior art keywords
drug
layer
compounds
skin
formula
Prior art date
Application number
LTIP111A
Other languages
English (en)
Lithuanian (lt)
Inventor
Harry Jalonen
Risto Lammintausta
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of LTIP111A publication Critical patent/LTIP111A/lt
Publication of LT3005B publication Critical patent/LT3005B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LTIP111A 1991-05-31 1992-05-29 Tam tikru terapiskai aktyviu 4-pakeistu imidazolu panaudojimas perodiniu farmaciniu preparatu gamybai LT3005B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9111773A GB2256135B (en) 1991-05-31 1991-05-31 Transdermal administration of 4-substituted imidazoles

Publications (2)

Publication Number Publication Date
LTIP111A LTIP111A (lt) 1994-03-25
LT3005B true LT3005B (lt) 1994-08-25

Family

ID=10695905

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP111A LT3005B (lt) 1991-05-31 1992-05-29 Tam tikru terapiskai aktyviu 4-pakeistu imidazolu panaudojimas perodiniu farmaciniu preparatu gamybai

Country Status (18)

Country Link
US (1) US5464628A (de)
EP (1) EP0586467B1 (de)
JP (1) JP3269822B2 (de)
AT (1) ATE199317T1 (de)
AU (1) AU1780892A (de)
CA (1) CA2110162C (de)
DE (1) DE69231709T2 (de)
DK (1) DK0586467T3 (de)
EE (1) EE02994B1 (de)
ES (1) ES2154636T3 (de)
FI (1) FI935350A (de)
GB (1) GB2256135B (de)
GR (1) GR3035499T3 (de)
IE (1) IE66188B1 (de)
LT (1) LT3005B (de)
LV (1) LV10042B (de)
NO (1) NO307365B1 (de)
WO (1) WO1992021334A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
TW200306783A (en) 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
ES2536478T3 (es) * 2004-12-15 2015-05-25 Teikoku Seiyaku Co., Ltd. Parches externos que contienen etofenamato
EP1981880B1 (de) 2006-01-27 2010-02-24 F.Hoffmann-La Roche Ag Verwendung von 4-imidazol-derivaten für zns-erkrankungen
CA2659379A1 (en) * 2006-08-08 2008-02-14 Intervet International B.V. Composition for enhanced antiparasitic activity
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
WO2020016827A1 (en) * 2018-07-18 2020-01-23 Clexio Biosciences Ltd. Purified crystalline detomidine hydrochloride monohydrate, anhydrate and free base with low amounts of iso-detomidine and other impurities by recrystallisation in water
MX2021012824A (es) 2019-05-01 2022-10-19 Clexio Biosciences Ltd Métodos para tratar el prurito.
CN112220767B (zh) * 2020-09-25 2022-10-25 安徽省公众检验研究院有限公司 一种盐酸阿替美唑缓释片的制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024829A1 (de) 1979-08-07 1981-03-11 Farmos-Yhtyma Oy 4-Benzyl- und 4-Benzoyl-imidazolderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0034474A1 (de) 1980-02-13 1981-08-26 Farmos-Yhtyma Oy Substituierte Imidazole, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0072615A1 (de) 1981-07-10 1983-02-23 Farmos Group Ltd. Substituierte Imidazolderivate und deren Herstellung und Anwendung
EP0183492A1 (de) 1984-11-23 1986-06-04 Farmos-Yhtyma Oy Substituierte Imidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0198492A2 (de) 1985-04-19 1986-10-22 Siemens Aktiengesellschaft Polarisiertes elektromagnetisches Relais
US4783477A (en) 1986-11-11 1988-11-08 Farmos-Yhtyma Oy Anxiolytic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024829A1 (de) 1979-08-07 1981-03-11 Farmos-Yhtyma Oy 4-Benzyl- und 4-Benzoyl-imidazolderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0034474A1 (de) 1980-02-13 1981-08-26 Farmos-Yhtyma Oy Substituierte Imidazole, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0034473A2 (de) 1980-02-13 1981-08-26 Farmos-Yhtyma Oy Substituierte Imidazole, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0072615A1 (de) 1981-07-10 1983-02-23 Farmos Group Ltd. Substituierte Imidazolderivate und deren Herstellung und Anwendung
EP0183492A1 (de) 1984-11-23 1986-06-04 Farmos-Yhtyma Oy Substituierte Imidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0198492A2 (de) 1985-04-19 1986-10-22 Siemens Aktiengesellschaft Polarisiertes elektromagnetisches Relais
US4783477A (en) 1986-11-11 1988-11-08 Farmos-Yhtyma Oy Anxiolytic composition

Also Published As

Publication number Publication date
GB9111773D0 (en) 1991-07-24
FI935350A0 (fi) 1993-11-30
AU1780892A (en) 1993-01-08
US5464628A (en) 1995-11-07
JP3269822B2 (ja) 2002-04-02
EE02994B1 (et) 1997-06-16
NO307365B1 (no) 2000-03-27
ES2154636T3 (es) 2001-04-16
CA2110162A1 (en) 1992-12-10
CA2110162C (en) 2002-11-12
LV10042A (lv) 1994-05-10
WO1992021334A1 (en) 1992-12-10
NO934261D0 (no) 1993-11-25
LTIP111A (lt) 1994-03-25
IE921938A1 (en) 1992-12-02
ATE199317T1 (de) 2001-03-15
IE66188B1 (en) 1995-12-13
GB2256135B (en) 1995-01-18
DE69231709T2 (de) 2001-10-04
GR3035499T3 (en) 2001-06-29
EP0586467A1 (de) 1994-03-16
FI935350A (fi) 1993-11-30
EP0586467B1 (de) 2001-02-28
DE69231709D1 (de) 2001-04-05
NO934261L (no) 1993-11-25
GB2256135A (en) 1992-12-02
LV10042B (en) 1995-02-20
JPH06507618A (ja) 1994-09-01
DK0586467T3 (da) 2001-03-26

Similar Documents

Publication Publication Date Title
CA1192496A (en) Topical pharmaceutical compositions
CA2696632C (en) High concentration local anesthetic formulations
EP0587819B1 (de) Medetomidine zusammensetzungen für die transdermale verabreichung
KR20000035800A (ko) 침투증강제로써글리콜산지방산에스테르및이의염
LT3005B (lt) Tam tikru terapiskai aktyviu 4-pakeistu imidazolu panaudojimas perodiniu farmaciniu preparatu gamybai
US20120213843A1 (en) Composition for promoting wound healing
AU2010351562B2 (en) Local anesthetic emulsion compositions and methods of making and using the same
US4777047A (en) Transdermal application form of calcium antagonists
US5750140A (en) Transdermal delivery of tiagabine
ES2210168T3 (es) Dispositivo transdermico de lasofoxileno.
KR20070059079A (ko) 경피 페로스피론 투여용 의약적 조성물
KR100192149B1 (ko) 경피 투여형 제제
JP2782118B2 (ja) 経皮吸収促進組成物及び経皮外用組成物
FI84696C (fi) Foerfarande foer framstaellning av en indometacininnehaollande salvakomposition.

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20060529